Hong Kong, China

Cong Ma

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cong Ma: Innovator in Antimicrobial and Antiviral Compounds

Introduction

Cong Ma is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with antimicrobial and antiviral properties. With a total of 2 patents, his work is recognized for its potential impact on treating various infections.

Latest Patents

Cong Ma's latest patents include innovative compounds aimed at combating viral infections. One of his notable inventions is titled "N-substituted oseltamivir derivatives with antimicrobial activity." This patent provides oseltamivir analogs that are useful for the treatment and prevention of viral infections, along with pharmaceutical compositions and methods for their preparation and use. Another significant patent involves "Compounds with antimicrobial activity," which relates to compounds that can treat bacterial and protozoal infections. These compounds are described by specific formulas and include methods for their administration in treating related disorders.

Career Highlights

Throughout his career, Cong Ma has worked with prestigious institutions, including The Hong Kong Polytechnic University and The Chinese University of Hong Kong. His research and innovations have contributed to advancements in pharmaceutical sciences, particularly in developing effective treatments for infectious diseases.

Collaborations

Cong Ma has collaborated with notable colleagues, including Xiao Yang and Jiqing Ye. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Cong Ma's contributions to the development of antimicrobial and antiviral compounds highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for new treatments that can address pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…